ReviewDigestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society2026
Endo-Hepatology: Paradigm Shift in Endosonographic Diagnosis for Liver Disease to Digestive Endoscopy.
Review in Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Assessment of liver disease has traditionally relied on a fragmented approach involving cross-sectional imaging, noninvasive fibrosis assessment, liver biopsy, and endoscopy for complications of portal hypertension. Although effective, this strategy often requires multiple procedures and lacks integration. Advances in endoscopic ultrasound (EUS) have led to the emergence of endo-hepatology, an integrated model enabling comprehensive evaluation and management of liver disease within a single endoscopic platform. This review highlights recent advances in endo-hepatology and the expanding diagnostic and therapeutic roles of EUS. High-resolution EUS imaging, enhanced by contrast-enhanced harmonic techniques, improves detection and characterization of focal liver lesions, including early hepatocellular carcinoma and small metastases. EUS-guided liver biopsy is a safe and effective alternative to percutaneous and transjugular approaches, providing high-quality tissue acquisition from both hepatic lobes. EUS-guided shear wave elastography allows accurate fibrosis assessment in patients with obesity or ascites, overcoming limitations of transabdominal techniques. EUS-guided portal pressure gradient measurement offers direct assessment of portal hypertension without radiation or contrast exposure. Therapeutic EUS applications, including coil and glue therapy for gastric varices and emerging locoregional treatments for liver tumors, offer minimally invasive options in selected patients. Collectively, these advances support EUS as a potential "one-stop" modality for liver disease assessment and management. As evidence continues to accumulate, endo-hepatology is likely to assume an increasingly central role in modern hepatology practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.